Isabelle Durand-Zaleski

//Isabelle Durand-Zaleski
Isabelle Durand-Zaleski2019-01-11T14:48:42+00:00
Isabelle Durand-Zaleski

Isabelle Durand-Zaleski, MD, PhD

 

As the chief of the Paris  research unit on health econmics and health services research,  I am in charge of developing methods to support clinical research, for the assessment of new technologies, including the economic assessment.  I teach health economics and health technology assessment at the university of Paris Est.

Research interests include health policy and political economy (the translation of research finding into policies and assessment of innovation in medicine.

Orcid number : 0000-0002-4078-1476

Best publications

  • Javaud N, Fain O, Durand-Zaleski I, Launay D, Bouillet L, Gompel A, Sobel A, Woimant M, Rabetrano H, Petrovic T, Lapostolle F, Boccon-Gibod I, Reuter PG, Bertrand P, Mezaour M, Coppere B, Floccard B, Kanny G, Baker E, Martin L, Vicaut E, Adnet F.Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial.Ann Emerg Med. 2018 Aug;72(2):194-203.e1.

  • Javaud N, Bouillet L, Rabetrano H, Bitoun A, Launay D, Lapostolle F, Reuter PG, Martin L, Vicaut E, Fain O, Adnet F, Durand-Zaleski I; SOS-HAE Collaborative Study Group.Hereditary angioedema: Clinical presentation and socioeconomic cost of 200 French patients.J Allergy Clin Immunol Pract. 2019 Jan;7(1):328-330.

  • Durand-Zaleski I, Mutuon P, Charreau I, Tremblay C, Rojas D, Pialoux G, Chidiac C, Capitant C, Spire B, Cotte L, Chas J, Meyer L; Jean Michel MOLINA for
    the ANRS IPERGAY Study Group. Costs and benefits of On-Demand HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men Analysis of the ANRS IPERGAY study with  a one-year follow-up. AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001658. [Epub ahead of print] PubMed PMID: 29028656.

  • Cadier B, Bulsei J, Nahon P, Seror O, Laurent A, Rosa I, Layese R, Costentin C, Cagnot C, Durand-Zaleski I, Chevreul K; ANRS CO12 CirVir and CHANGH groups.
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States. Hepatology. 2017  Apr;65(4):1237-1248. doi: 10.1002/hep.28961. Epub 2017 Feb 8. PubMed PMID: 28176349.

  • Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C,  Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group. Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema:  The REVOLENS Randomized Clinical Trial. JAMA. 2016 Jan 12;315(2):175-84. doi: 10.1001/jama.2015.17821. PubMed PMID: 26757466.